(561) 802-3060 info@mri-news.com
Does Losing Weight Seem Out Of Reach?

Does Losing Weight Seem Out Of Reach?

If you’re struggling to lose weight on your own, you may be interested in participating in the SURMOUNT-3 Study.  In addition to a potential new investigational weight management option, study participants will also receive counseling and support to make healthier choices.

Qualified candidates will be men and women 18 years of age or older with no history of Diabetes (Type 1 or Type 2).
Additional eligibility criteria also apply.

Study participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.

For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute:
(561) 802-3060, ext. 8036 or visit:  https://www.metabolic-institute.com/weight-loss-study/

Join the search for an effective NASH therapy

Join the search for an effective NASH therapy

Learn about an investigational drug for nonalcoholic steatohepatitis (NASH) in the NASH-FXR study.

Study qualification requirements
•  18-75 years old
•  Confirmed or suspected NASH diagnosis. Study staff will confirm if you have NASH during the  pre-screening part of the study
•  No current drug abuse or excessive alcohol consumption
Other requirements will apply.

Qualified participants will receive at no cost:
•  Potential access to the investigational study drug
•  Study-related support and monitoring by a healthcare team
•  Education about NASH
•  Reimbursement for time and travel

For more information about the NASH FXR study, call Metabolic Research Institute (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/nash-fxr-study/

Currently Enrolling Studies

Currently Enrolling Studies

Metabolic Research Institute in West Palm Beach is currently recruiting qualified volunteers to participate in the following studies:

1. CAH Study: Congenital adrenal disorders (hyperplasia)
2. Insulin Study for Type 2 Diabetes using Continuous Glucose Monitoring (CGM)
3. Insulin Study for Type 2 Diabetes comparing a once-weekly study drug to insulin, in patients with type 2 diabetes
4. Oral Insulin for Type 2 Diabetes
5. Clinical trial evaluating use of the Freestyle Libre 2 Flash Glucose Monitoring System in Type 2 Diabetes
6. A once-weekly investigative insulin in the treatment of Type 2 Diabetes

7. Diabetes Peripheral Neuropathy (DPN) study for Type 1 and Type 2 Diabetes

There is no cost to participate in these research studies, and health insurance is not required.

Qualified participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.

For additional information on any of these studies, please call Metabolic Research Institute: (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/currently-enrolling…/

*We respect your privacy. All information submitted in this form is transmitted over secure servers, and will be kept strictly confidential except as required by law. In response to your inquiry, your information will be added to our in-house database and you will be contacted by email and/or phone by a member of the clinical study team to discuss research opportunities available to you.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.

What’s Missing From Your Type 2 Diabetes Management?

What’s Missing From Your Type 2 Diabetes Management?

If you have type 2 diabetes that is inadequately controlled with insulin, the SURPASS-6 Study may interest you. We are evaluating the safety and effectiveness of a once-weekly study drug compared to insulin, in patients with type 2 diabetes.
 
Qualified candidates will:
• be men and women 18 years of age or older
• be diagnosed with Type 2 Diabetes for at least one year
• have been treated with long acting (basal) insulin with or without other diabetic medications to control their diabetes for at least 90 days
 
Additional eligibility criteria also apply.
 
Qualified participants will receive all study related examinations, lab tests and study medications at no cost. You may also be reimbursed for your time and travel.
 
Clinical research study enrolling now
 
For more information:
Metabolic Research Institute Inc.
(561) 802-3060, ext. 8036
metabolic-institute.com/DM2-on-insulin

Diabetes Care App for Type 2 Diabetes

Research Study Enrolling in West Palm Beach FL

Diabetes care app for Type 2 Diabetes Study Flyer

The diabetes care app is a smartphone app available on iOS and Android platforms intended to provide relevant education content and tracking capabilities for people with diabetes, specifically focusing on those with type 2 diabetes.

To learn more about this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit:
https://www.metabolic-institute.com/BD

ABOUT METABOLIC RESEARCH INSTITUTE, INC. (“MRI”)
Clinical studies are an integral part of clinical research and are at the heart of all advances in modern medicine. Our mission at the Metabolic Research Institute is to provide our patients and sponsors with the highest quality of diabetes clinical research available in today’s medical professional environment. We are committed to delivering efficient and timely research data, while focusing on strict adherence to protocol guidelines.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address

Type 1 Diabetes Clinical Study

Medtronic Minimed 670G insulin pump

Type 1 Diabetes Clinical Study enrolling now in West Palm Beach FL

Qualified candidates will be:
• Men and women 18 to 80 years of age
• Diagnosed with Type 1 Diabetes for at least 1 year
• Currently using the Medtronic Minimed 670G Insulin Pump
• Willing to wear each Extended Wear Infusion Set for at least 174 hours (7days & 6 hours) or until infusion set failure

Additional eligibility criteria also apply.

Qualified participants will receive all study-related medications, laboratory tests and study-related supplies at no cost. You may also be reimbursed for your time and travel.

The Extended Wear Infusion Set (EWIS) is an investigational study. Its purpose is to collect data to support the safety and effectiveness of wearing the EWIS infusion set for 6 to 7 days. This study will last approximately 12 to 16 weeks, and will consist of 5 on-site and 2 telephone visits.

Important Safety Information for MiniMed™ 670G System: The MiniMed™ 670G is for type 1 ages 7 and over. Prescription required. Individual results may vary. WARNING: May not be safe under age 7 or using less than 8 units/day.

For more information, please call: (561) 802-3060, or visit: https: www.metabolic-institute.com/EWIS

Metabolic Research Institute Inc.
Barry S. Horowitz, MD, FACE – Principal Investigator
1515 N. Flagler Drive, Suite 440
West Palm Beach, FL 33401
Study Sponsor: Medtronic Diabetes 18000 Devonshire Street Northridge, CA 91325